AlphaStocks
4.9
Weak

AMGEN INC (AMGN)

Health Care / Biotechnology

S&P 500

$337.47

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#565out of 1124 in Health Care

Is AMGEN INC a Good Investment in 2026?

AMGEN INC (AMGN) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates AMGEN INC as Strong (7/9). However, the Graham model rates it Caution — Significantly above fair value. AMGEN INC currently trades above its estimated fair value of $336, suggesting limited upside at current prices. AMGEN INC ranks #565 out of 1124 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E23.7ROE22.7Market Cap184BDiv Yield2.9

Estimated Fair Value

$336.200% above

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 3.8 · Stalwart

Greenblatt

Neutral

Top 25% (rank 12%)

Frequently Asked Questions

Is AMGEN INC (AMGN) a good investment?
Based on AlphaStocks' composite analysis, AMGEN INC (AMGN) scores 4.9 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading near estimated fair value.
What is AMGEN INC's Piotroski F-Score?
AMGEN INC's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AMGN overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $336, AMGN appears overvalued. The stock currently trades 0% above its estimated fair value. Trading near estimated fair value.
How does AMGN compare to other Health Care stocks?
AMGEN INC ranks #565 out of 1124 stocks in the Health Care sector, placing it in the top 50% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about AMGN?
AlphaStocks evaluates AMGN using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 4.9/10.

Similar Stocks

BFAMPARRAZN

Compare AMGN with

AMGN vs BFAMAMGN vs PARRAMGN vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer